| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2021―Jun―16 |
Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS-CoV-2 in the United Kingdom |
Joseph G. Chappell, Theocharis Tsoleridis, Gemma Clark, Louise Berry, Nadine Holmes, Christopher Moore, et al. (+18) Matthew Carlile, Fei Sang, Bisrat J. Debebe, Victoria Wright, William L. Irving, Brian J. Thomson, Timothy C. J. Boswell, Iona Willingham, Amelia Joseph, Wendy Smith, Manjinder Khakh, Vicki M. Fleming, Michelle M. Lister, Hannah C. Howson-Wells, Edward C. Holmes, Matthew W. Loose, Jonathan K. Ball, C. Patrick McClure |
| 2 |
[GO] |
2021―May―06 |
Differential role of sphingomyelin in influenza virus, rhinovirus and SARS-CoV-2 infection of Calu-3 cells |
Thrimendra Kaushika Dissanayake, Bingpeng Yan, Anthony Chin-Ki Ng, Hanjun Zhao, Gabriella Chan, Cyril Chik-Yan Yip, et al. (+2) Kong-Hung Sze, Kelvin Kai-Wang To |
| 3 |
[GO] |
2021―May―06 |
SARS-CoV-2 replicon for high-throughput antiviral screening |
Qiu-Yan Zhang, Cheng-Lin Deng, Jing Liu, Jia-Qi Li, Hong-Qing Zhang, Na Li, et al. (+5) Ya-Nan Zhang, Xiao-Dan Li, Bo Zhang, Yi Xu, Han-Qing Ye |
| 4 |
[GO] |
2021―Apr―29 |
Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes |
Katherine Davies, Hubert Buczkowski, Stephen R. Welch, Nicole Green, Damian Mawer, Neil Woodford, et al. (+4) Allen D. G. Roberts, Peter J. Nixon, David W. Seymour, Marian J. Killip |
| 5 |
[GO] |
2021―Apr―23 |
Investigative study into whether an insect repellent has virucidal activity against SARS-CoV-2 |
Sophie J. Smither, Lin S. Eastaugh, James S. Findlay, Thomas R. Laws, Stephen N. Marriott, Stuart Notman, et al. (+7) Lyn M. O’Brien, Amanda L. Phelps, Mark Richards, David Ulaeto, Pat Watts, Mark S. Lever, Norman Govan |
| 6 |
[GO] |
2021―Apr―15 |
SARS-CoV-2 one year on: evidence for ongoing viral adaptation |
Thomas P. Peacock, Rebekah Penrice-Randal, Julian A. Hiscox, Wendy S. Barclay |
| 7 |
[GO] |
2021―Apr―08 |
The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection |
Lisa Henss, Arne Auste, Christoph Schürmann, Christin Schmidt, Christine von Rhein, Michael D. Mühlebach, Barbara S. Schnierle |
| 8 |
[GO] |
2021―Feb―22 |
Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2 |
Elodie Monchatre-Leroy, Sandrine Lesellier, Marine Wasniewski, Evelyne Picard-Meyer, Céline Richomme, Franck Boué, et al. (+8) Sandra Lacôte, Séverine Murri, Coralie Pulido, Johann Vulin, Francisco J. Salguero, Meriadeg Ar Gouilh, Alexandre Servat, Philippe Marianneau |
| 9 |
[GO] |
2021―Feb―15 |
A comprehensive profile of genomic variations in the SARS-CoV-2 isolates from the state of Telangana, India |
Asmita Gupta, Radhakrishnan Sabarinathan, Pratyusha Bala, Vinay Donipadi, Divya Vashisht, Madhumohan Rao Katika, et al. (+4) Manohar Kandakatla, Debashis Mitra, Ashwin Dalal, Murali Dharan Bashyam |
| 10 |
[GO] |
2021―Jan―28 |
Targeting novel structural and functional features of coronavirus protease nsp5 (3CLpro, Mpro) in the age of COVID-19 |
Molly K. Roe, Nathan A. Junod, Audrey R. Young, Dia C. Beachboard, Christopher C. Stobart |
| 11 |
[GO] |
2021―Jan―11 |
A genetic element in the SARS-CoV-2 genome is shared with multiple insect species |
Torstein Tengs, Charles F. Delwiche, Christine Monceyron Jonassen |
| 12 |
[GO] |
2021―Jan―08 |
Assessment of inactivation procedures for SARS-CoV-2 |
Heidi Auerswald, Sokhoun Yann, Sokha Dul, Saraden In, Philippe Dussart, Nicholas J. Martin, et al. (+2) Erik A. Karlsson, Jose A. Garcia-Rivera |
| 13 |
[GO] |
2020―Dec―17 |
Understanding the outcomes of COVID-19 - does the current model of an acute respiratory infection really fit? |
Peter Simmonds, Sarah Williams, Heli Harvala |
| 14 |
[GO] |
2020―Nov―05 |
Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression |
Zhou Shen, Guangxu Zhang, Yilin Yang, Mengxia Li, Siqi Yang, Guiqing Peng |
| 15 |
[GO] |
2020―Sep―30 |
Microbiology Society online workshop on SARS-CoV-2 and COVID-19, Wednesday 29 July 2020 |
Mark Harris |
| 16 |
[GO] |
2020―Sep―09 |
Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus |
Arinjay Banerjee, Andrew C. Doxey, Benjamin J.-M. Tremblay, Michael J. Mansfield, Sonu Subudhi, Jeremy A. Hirota, et al. (+4) Matthew S. Miller, Andrew G. McArthur, Samira Mubareka, Karen Mossman |
| 17 |
[GO] |
2020―Sep―09 |
Analysis of partial sequences of the RNA-dependent RNA polymerase gene as a tool for genus and subgenus classification of coronaviruses |
David A. Wilkinson, Léa Joffrin, Camille Lebarbenchon, Patrick Mavingui |
| 18 |
[GO] |
2020―Sep―07 |
Construction and efficacy evaluation of novel swine leukocyte antigen (SLA) class I and class II allele-specific poly-T cell epitope vaccines against porcine reproductive and respiratory syndrome virus |
Debin Tian, Sakthivel Subramaniam, C. Lynn Heffron, Hassan M. Mahsoub, Harini Sooryanarain, Bo Wang, et al. (+6) Qian M. Cao, Anna Hassebroek, Tanya LeRoith, Dennis L. Foss, Jay G. Calvert, Xiang-Jin Meng |
| 19 |
[GO] |
2020―Aug―21 |
SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients |
William B. Klimstra, Natasha L. Tilston-Lunel, Sham Nambulli, James Boslett, Cynthia M. McMillen, Theron Gilliland, et al. (+9) Matthew D. Dunn, Chengun Sun, Sarah E. Wheeler, Alan Wells, Amy L. Hartman, Anita K. McElroy, Douglas S. Reed, Linda J. Rennick, W. Paul Duprex |
| 20 |
[GO] |
2020―Jul―28 |
Multiple novel non-canonically transcribed sub-genomic mRNAs produced by avian coronavirus infectious bronchitis virus |
Sarah Keep, Michael S. Oade, Filip Lidzbarski-Silvestre, Kirsten Bentley, Phoebe Stevenson-Leggett, Graham L. Freimanis, et al. (+6) Chandana Tennakoon, Nicholas Sanderson, John A. Hammond, Richard C. Jones, Paul Britton, Erica Bickerton |
| 21 |
[GO] |
2020―Jul―15 |
A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a |
Andrew E. Firth |
| 22 |
[GO] |
2020―Jun―24 |
Insights into SARS-CoV-2, the Coronavirus Underlying COVID-19: Recent Genomic Data and the Development of Reverse Genetics Systems |
Severino Jefferson Ribeiro da Silva, Renata Pessôa Germano Mendes, Caroline Targino Alves da Silva, Alessio Lorusso, Alain Kohl, Lindomar Pena |
| 23 |
[GO] |
2020―Jun―15 |
Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection |
Jingfang Wang, Xintian Xu, Xinbo Zhou, Ping Chen, Huiying Liang, Xuan Li, et al. (+2) Wu Zhong, Pei Hao |
| 24 |
[GO] |
2020―May―20 |
The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection |
Paul Kellam, Wendy Barclay |
|
